Antiverse is a series a startup. 2 investors tracked. Status: possibledead.
Based in the United Kingdom, Antiverse is a startup. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Antiverse is a biotechnology company developing a computational antibody drug discovery platform.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.